Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v2-FR
Language English French
Date Updated 2017-10-10 2017-03-13
Drug Identification Number 02350327 02350327
Brand name RATIO-ATORVASTATIN RATIO-ATORVASTATIN
Common or Proper name ATORVASTATIN ATORVASTATIN
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients ATORVASTATIN ATORVASTATIN
Strength(s) 40MG 40MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 30
ATC code C10AA C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-06-29 2016-06-29
Estimated end date Unknown 2017-06-30
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments